{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T05:22:24Z","timestamp":1792041744493,"version":"4.4.0"},"reference-count":147,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2021,6,1]]},"DOI":"10.1001\/jamaneurol.2021.0873","type":"journal-article","created":{"date-parts":[[2021,4,26]],"date-time":"2021-04-26T15:07:50Z","timestamp":1619449670000},"page":"666","source":"Crossref","is-referenced-by-count":83,"title":["Sex Disparities in Enrollment in Recent Randomized Clinical Trials of Acute Stroke"],"prefix":"10.1001","volume":"78","author":[{"given":"Brent","family":"Strong","sequence":"first","affiliation":[{"name":"Department of Epidemiology and Biostatistics, College of Human Medicine, Michigan State University, East Lansing"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Pudar","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, College of Human Medicine, Michigan State University, East Lansing"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda G.","family":"Thrift","sequence":"additional","affiliation":[{"name":"Stroke and Ageing Research, Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia J.","family":"Howard","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, School of Public Health, University of Alabama at Birmingham, Birmingham"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murtaza","family":"Hussain","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, College of Human Medicine, Michigan State University, East Lansing"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl","family":"Carcel","sequence":"additional","affiliation":[{"name":"George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo","family":"de los Campos","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, College of Human Medicine, Michigan State University, East Lansing"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathew J.","family":"Reeves","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, College of Human Medicine, Michigan State University, East Lansing"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"3","key":"noi210017r1","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1089\/jwh.2010.2469","article-title":"Inclusion, analysis, and reporting of sex and race\/ethnicity in clinical trials: have we made progress?","volume":"20","author":"Geller","year":"2011","journal-title":"J Womens Health (Larchmt)"},{"issue":"9","key":"noi210017r2","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1177\/1747493019851292","article-title":"Trends in recruitment of women and reporting of sex differences in large-scale published randomized controlled trials in stroke.","volume":"14","author":"Carcel","year":"2019","journal-title":"Int J Stroke"},{"issue":"7","key":"noi210017r3","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1161\/CIRCULATIONAHA.119.043594","article-title":"Women\u2019s participation in cardiovascular clinical trials from 2010 to 2017.","volume":"141","author":"Jin","year":"2020","journal-title":"Circulation"},{"issue":"4","key":"noi210017r4","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1212\/WNL.0b013e3182088260","article-title":"Enrollment of women and minorities in NINDS trials.","volume":"76","author":"Burke","year":"2011","journal-title":"Neurology"},{"issue":"11","key":"noi210017r5","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.015594","article-title":"Ten-year trends in enrollment of women and minorities in pivotal trials supporting recent US Food and Drug Administration approval of novel cardiometabolic drugs.","volume":"9","author":"Khan","year":"2020","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"noi210017r6","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.118.004713","article-title":"Evolution of age and female representation in the most-cited randomized controlled trials of cardiology of the last 20 years.","volume":"11","author":"Nguyen","year":"2018","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"10","key":"noi210017r7","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1001\/jamacardio.2018.2559","article-title":"Enrollment of older patients, women, and racial and ethnic minorities in contemporary heart failure clinical trials: a systematic review.","volume":"3","author":"Tahhan","year":"2018","journal-title":"JAMA Cardiol"},{"issue":"6","key":"noi210017r8","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1001\/jamacardio.2020.0359","article-title":"Enrollment of older patients, women, and racial\/ethnic minority groups in contemporary acute coronary syndrome clinical trials: a systematic review.","volume":"5","author":"Tahhan","year":"2020","journal-title":"JAMA Cardiol"},{"issue":"18","key":"noi210017r9","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1016\/j.jacc.2018.02.070","article-title":"Participation of women in clinical trials supporting FDA approval of cardiovascular drugs.","volume":"71","author":"Scott","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"10029","key":"noi210017r10","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1016\/S0140-6736(16)00163-X","article-title":"Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials.","volume":"387","author":"Goyal","year":"2016","journal-title":"Lancet"},{"issue":"1","key":"noi210017r11","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1706442","article-title":"Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct.","volume":"378","author":"Nogueira","year":"2018","journal-title":"N Engl J Med"},{"issue":"8","key":"noi210017r12","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1056\/NEJMoa1713973","article-title":"Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging.","volume":"378","author":"Albers","year":"2018","journal-title":"N Engl J Med"},{"issue":"3","key":"noi210017r13","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1056\/NEJMoa1800410","article-title":"Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA.","volume":"379","author":"Johnston","year":"2018","journal-title":"N Engl J Med"},{"issue":"1","key":"noi210017r14","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1215340","article-title":"Clopidogrel with aspirin in acute minor stroke or transient ischemic attack.","volume":"369","author":"Wang","year":"2013","journal-title":"N Engl J Med"},{"issue":"10227","key":"noi210017r15","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/S0140-6736(20)30258-0","article-title":"Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial.","volume":"395","author":"Hill","year":"2020","journal-title":"Lancet"},{"issue":"12","key":"noi210017r16","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1177\/0271678X18793324","article-title":"Sex differences in stroke: Challenges and opportunities.","volume":"38","author":"Bushnell","year":"2018","journal-title":"J Cereb Blood Flow Metab"},{"issue":"10159","key":"noi210017r17","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.","volume":"392","author":"James","year":"2018","journal-title":"Lancet"},{"issue":"7","key":"noi210017r18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"issue":"33","key":"noi210017r19","doi-asserted-by":"publisher","first-page":"3992","DOI":"10.1200\/JCO.2016.67.7088","article-title":"Enrollment trends and disparity among patients with lung cancer in national clinical trials, 1990 to 2012.","volume":"34","author":"Pang","year":"2016","journal-title":"J Clin Oncol"},{"issue":"2","key":"noi210017r20","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/jrsm.12","article-title":"A basic introduction to fixed-effect and random-effects models for meta-analysis.","volume":"1","author":"Borenstein","year":"2010","journal-title":"Res Synth Methods"},{"issue":"7414","key":"noi210017r21","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses.","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"issue":"17","key":"noi210017r22","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1002\/(ISSN)1097-0258","article-title":"Improved tests for a random effects meta-regression with a single covariate.","volume":"22","author":"Knapp","year":"2003","journal-title":"Stat Med"},{"issue":"11","key":"noi210017r23","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1002\/(ISSN)1097-0258","article-title":"How should meta-regression analyses be undertaken and interpreted?","volume":"21","author":"Thompson","year":"2002","journal-title":"Stat Med"},{"issue":"4","key":"noi210017r24","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1161\/STROKEAHA.119.027569","article-title":"Dabigatran treatment of acute noncardioembolic ischemic stroke.","volume":"51","author":"Butcher","year":"2020","journal-title":"Stroke"},{"issue":"13","key":"noi210017r25","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1001\/jama.2020.1511","article-title":"Effect of intravenous tenecteplase dose on cerebral reperfusion before thrombectomy in patients with large vessel occlusion ischemic stroke: the EXTEND-IA TNK Part 2 randomized clinical trial.","volume":"323","author":"Campbell","year":"2020","journal-title":"JAMA"},{"issue":"3","key":"noi210017r26","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/S1474-4422(20)30004-1","article-title":"Safety and efficacy of GABAA a5 antagonist S44819 in patients with ischaemic stroke: a multicentre, double-blind, randomised, placebo-controlled trial.","volume":"19","author":"Chabriat","year":"2020","journal-title":"Lancet Neurol"},{"issue":"5","key":"noi210017r27","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1161\/STROKEAHA.119.028127","article-title":"Thrombolysis with alteplase at 0.6 mg\/kg for stroke with unknown time of onset: a randomized controlled trial.","volume":"51","author":"Koga","year":"2020","journal-title":"Stroke"},{"issue":"2","key":"noi210017r28","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S1474-4422(19)30395-3","article-title":"Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial.","volume":"19","author":"Liu","year":"2020","journal-title":"Lancet Neurol"},{"issue":"24","key":"noi210017r29","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.1056\/NEJMoa2000120","article-title":"Thrombectomy for stroke in the public health care system of Brazil.","volume":"382","author":"Martins","year":"2020","journal-title":"N Engl J Med"},{"issue":"6","key":"noi210017r30","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1001\/jamaneurol.2020.0326","article-title":"Effect of in-hospital remote ischemic perconditioning on brain infarction growth and clinical outcomes in patients with acute ischemic stroke: the RESCUE BRAIN randomized clinical trial.","volume":"77","author":"Pico","year":"2020","journal-title":"JAMA Neurol"},{"issue":"21","key":"noi210017r31","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1056\/NEJMoa2001123","article-title":"Endovascular thrombectomy with or without intravenous alteplase in acute stroke.","volume":"382","author":"Yang","year":"2020","journal-title":"N Engl J Med"},{"issue":"4","key":"noi210017r32","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/S1474-4422(19)30026-2","article-title":"Safety and efficacy of sonothrombolysis for acute ischaemic stroke: a multicentre, double-blind, phase 3, randomised controlled trial.","volume":"18","author":"Alexandrov","year":"2019","journal-title":"Lancet Neurol"},{"issue":"10174","key":"noi210017r33","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/S0140-6736(19)30038-8","article-title":"Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial.","volume":"393","author":"Anderson","year":"2019","journal-title":"Lancet"},{"issue":"21","key":"noi210017r34","doi-asserted-by":"publisher","first-page":"e1955","DOI":"10.1212\/WNL.0000000000008520","article-title":"Therapeutic-induced hypertension in patients with noncardioembolic acute stroke.","volume":"93","author":"Bang","year":"2019","journal-title":"Neurology"},{"issue":"10175","key":"noi210017r35","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/S0140-6736(19)30194-1","article-title":"Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke (RIGHT-2): an ambulance-based, randomised, sham-controlled, blinded, phase 3 trial.","volume":"393","author":"Bath","year":"2019","journal-title":"Lancet"},{"issue":"10194","key":"noi210017r36","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S0140-6736(19)31192-4","article-title":"An injectable implant to stimulate the sphenopalatine ganglion for treatment of acute ischaemic stroke up to 24 h from onset (ImpACT-24B): an international, randomised, double-blind, sham-controlled, pivotal trial.","volume":"394","author":"Bornstein","year":"2019","journal-title":"Lancet"},{"issue":"8","key":"noi210017r37","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1161\/STROKEAHA.118.024582","article-title":"Sphenopalatine ganglion stimulation to augment cerebral blood flow: a randomized, sham-controlled trial.","volume":"50","author":"Bornstein","year":"2019","journal-title":"Stroke"},{"issue":"10168","key":"noi210017r38","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S0140-6736(18)32823-X","article-title":"Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial.","volume":"393","author":"Dennis","year":"2019","journal-title":"Lancet"},{"issue":"10175","key":"noi210017r39","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/S0140-6736(19)30195-3","article-title":"Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial.","volume":"393","author":"Hanley","year":"2019","journal-title":"Lancet"},{"issue":"4","key":"noi210017r40","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1001\/jama.2019.9346","article-title":"Intensive vs standard treatment of hyperglycemia and functional outcome in patients with acute ischemic stroke: the SHINE randomized clinical trial.","volume":"322","author":"Johnston","year":"2019","journal-title":"JAMA"},{"issue":"19","key":"noi210017r41","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1056\/NEJMoa1813046","article-title":"Thrombolysis guided by perfusion imaging up to 9 hours after onset of stroke.","volume":"380","author":"Ma","year":"2019","journal-title":"N Engl J Med"},{"issue":"5","key":"noi210017r42","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1001\/jamaneurol.2018.4822","article-title":"Outcomes of hypothermia in addition to decompressive hemicraniectomy in treatment of malignant middle cerebral artery stroke: a randomized clinical trial.","volume":"76","author":"Neugebauer","year":"2019","journal-title":"JAMA Neurol"},{"issue":"5","key":"noi210017r43","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/S1474-4422(19)30069-9","article-title":"Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trial.","volume":"18","author":"Selim","year":"2019","journal-title":"Lancet Neurol"},{"issue":"10175","key":"noi210017r44","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/S0140-6736(19)30297-1","article-title":"Aspiration thrombectomy versus stent retriever thrombectomy as first-line approach for large vessel occlusion (COMPASS): a multicentre, randomised, open label, blinded outcome, non-inferiority trial.","volume":"393","author":"Turk","year":"2019","journal-title":"Lancet"},{"key":"noi210017r45","doi-asserted-by":"publisher","first-page":"l2211","DOI":"10.1136\/bmj.l2211","article-title":"Ticagrelor plus aspirin versus clopidogrel plus aspirin for platelet reactivity in patients with minor stroke or transient ischaemic attack: open label, blinded endpoint, randomised controlled phase II trial.","volume":"365","author":"Wang","year":"2019","journal-title":"BMJ"},{"issue":"10123","key":"noi210017r46","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/S0140-6736(17)32849-0","article-title":"Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial.","volume":"391","author":"Bath","year":"2018","journal-title":"Lancet"},{"issue":"1","key":"noi210017r47","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1161\/STROKEAHA.117.017956","article-title":"Induced hypertension for delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage: a randomized clinical trial.","volume":"49","author":"Gathier","year":"2018","journal-title":"Stroke"},{"issue":"2","key":"noi210017r48","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1001\/jama.2018.8496","article-title":"Effect of alteplase vs aspirin on functional outcome for patients with acute ischemic stroke and minor nondisabling neurologic deficits: the PRISMS randomized clinical trial.","volume":"320","author":"Khatri","year":"2018","journal-title":"JAMA"},{"issue":"11","key":"noi210017r49","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.1161\/STROKEAHA.117.020067","article-title":"Neuroregeneration and vascular protection by citalopram in acute ischemic stroke (TALOS).","volume":"49","author":"Kraglund","year":"2018","journal-title":"Stroke"},{"issue":"3","key":"noi210017r50","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1001\/jamaneurol.2017.3967","article-title":"Safety and efficacy of a 3-dimensional stent retriever with aspiration-based thrombectomy vs aspiration-based thrombectomy alone in acute ischemic stroke intervention: a randomized clinical trial.","volume":"75","author":"Nogueira","year":"2018","journal-title":"JAMA Neurol"},{"issue":"4","key":"noi210017r51","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1001\/jamaneurol.2017.4474","article-title":"Effect of general anesthesia and conscious sedation during endovascular therapy on infarct growth and clinical outcomes in acute ischemic stroke: a randomized clinical trial.","volume":"75","author":"Simonsen","year":"2018","journal-title":"JAMA Neurol"},{"issue":"10135","key":"noi210017r52","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1016\/S0140-6736(18)31033-X","article-title":"Tranexamic acid for hyperacute primary intracerebral haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial.","volume":"391","author":"Sprigg","year":"2018","journal-title":"Lancet"},{"issue":"7","key":"noi210017r53","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1056\/NEJMoa1804355","article-title":"MRI-guided thrombolysis for stroke with unknown time of onset.","volume":"379","author":"Thomalla","year":"2018","journal-title":"N Engl J Med"},{"issue":"25","key":"noi210017r54","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1056\/NEJMoa1615715","article-title":"Cluster-randomized, crossover trial of head positioning in acute stroke.","volume":"376","author":"Anderson","year":"2017","journal-title":"N Engl J Med"},{"issue":"3","key":"noi210017r55","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1161\/STROKEAHA.116.015042","article-title":"YAMATO study (tissue-type plasminogen activator and edaravone combination therapy).","volume":"48","author":"Aoki","year":"2017","journal-title":"Stroke"},{"issue":"6","key":"noi210017r56","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1161\/STROKEAHA.117.016720","article-title":"Randomized, multicenter trial of ARTSS-2 (argatroban with recombinant tissue plasminogen activator for acute stroke).","volume":"48","author":"Barreto","year":"2017","journal-title":"Stroke"},{"issue":"4","key":"noi210017r57","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1161\/STROKEAHA.116.015957","article-title":"PAIS 2 (paracetamol [Acetaminophen] in stroke 2): results of a randomized, double-blind placebo-controlled clinical trial.","volume":"48","author":"de Ridder","year":"2017","journal-title":"Stroke"},{"issue":"3","key":"noi210017r58","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S1474-4422(16)30357-X","article-title":"Safety and efficacy of natalizumab in patients with acute ischaemic stroke (ACTION): a randomised, placebo-controlled, double-blind phase 2 trial.","volume":"16","author":"Elkins","year":"2017","journal-title":"Lancet Neurol"},{"issue":"5","key":"noi210017r59","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1161\/STROKEAHA.116.014321","article-title":"ARTEMIDA Trial (A Randomized Trial of Efficacy, 12 Months International Double-Blind Actovegin): a randomized controlled trial to assess the efficacy of actovegin in poststroke cognitive impairment.","volume":"48","author":"Guekht","year":"2017","journal-title":"Stroke"},{"issue":"10069","key":"noi210017r60","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/S0140-6736(16)32410-2","article-title":"Thrombolytic removal of intraventricular haemorrhage in treatment of severe stroke: results of the randomised, multicentre, multiregion, placebo-controlled CLEAR III trial.","volume":"389","author":"Hanley","year":"2017","journal-title":"Lancet"},{"issue":"10","key":"noi210017r61","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1001\/jamaneurol.2017.2161","article-title":"Rivaroxaban vs warfarin sodium in the ultra-early period after atrial fibrillation-related mild ischemic stroke: a randomized clinical trial.","volume":"74","author":"Hong","year":"2017","journal-title":"JAMA Neurol"},{"issue":"5","key":"noi210017r62","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1001\/jama.2017.9644","article-title":"Effect of endovascular contact aspiration vs stent retriever on revascularization in patients with acute ischemic stroke and large vessel occlusion: the ASTER randomized clinical trial.","volume":"318","author":"Lapergue","year":"2017","journal-title":"JAMA"},{"issue":"10","key":"noi210017r63","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/S1474-4422(17)30253-3","article-title":"Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trial.","volume":"16","author":"Logallo","year":"2017","journal-title":"Lancet Neurol"},{"issue":"2","key":"noi210017r64","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1161\/STROKEAHA.116.014644","article-title":"NOR-SASS (Norwegian Sonothrombolysis in Acute Stroke Study): randomized controlled contrast-enhanced sonothrombolysis in an unselected acute ischemic stroke population.","volume":"48","author":"Nacu","year":"2017","journal-title":"Stroke"},{"issue":"12","key":"noi210017r65","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1001\/jama.2017.11463","article-title":"Effect of routine low-dose oxygen supplementation on death and disability in adults with acute stroke: the Stroke Oxygen Study randomized clinical trial.","volume":"318","author":"Roffe","year":"2017","journal-title":"JAMA"},{"issue":"2","key":"noi210017r66","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1161\/STROKEAHA.116.014803","article-title":"AMOBES (Active Mobility Very Early After Stroke): a randomized controlled trial.","volume":"48","author":"Yelnik","year":"2017","journal-title":"Stroke"},{"issue":"11","key":"noi210017r67","doi-asserted-by":"publisher","first-page":"3057","DOI":"10.1161\/STROKEAHA.117.017623","article-title":"Randomized controlled trial of early versus delayed statin therapy in patients with acute ischemic stroke: ASSORT trial (Administration of Statin on Acute Ischemic Stroke Patient).","volume":"48","author":"Yoshimura","year":"2017","journal-title":"Stroke"},{"issue":"1","key":"noi210017r68","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1161\/STROKEAHA.116.014285","article-title":"Perioperative antihypertensive treatment in patients with spontaneous intracerebral hemorrhage.","volume":"48","author":"Zheng","year":"2017","journal-title":"Stroke"},{"issue":"24","key":"noi210017r69","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1056\/NEJMoa1515510","article-title":"Low-Dose versus standard-dose intravenous alteplase in acute ischemic stroke.","volume":"374","author":"Anderson","year":"2016","journal-title":"N Engl J Med"},{"issue":"10038","key":"noi210017r70","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1016\/S0140-6736(16)30392-0","article-title":"Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial.","volume":"387","author":"Baharoglu","year":"2016","journal-title":"Lancet"},{"issue":"11","key":"noi210017r71","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1016\/S1474-4422(16)30177-6","article-title":"Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial.","volume":"15","author":"Bracard","year":"2016","journal-title":"Lancet Neurol"},{"issue":"9","key":"noi210017r72","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1161\/STROKEAHA.115.012293","article-title":"Recurrent ischemic lesions after acute atherothrombotic stroke: clopidogrel plus aspirin versus aspirin alone.","volume":"47","author":"Hong","year":"2016","journal-title":"Stroke"},{"issue":"1","key":"noi210017r73","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1056\/NEJMoa1603060","article-title":"Ticagrelor versus aspirin in acute stroke or transient ischemic attack.","volume":"375","author":"Johnston","year":"2016","journal-title":"N Engl J Med"},{"issue":"12","key":"noi210017r74","doi-asserted-by":"publisher","first-page":"2888","DOI":"10.1161\/STROKEAHA.116.014200","article-title":"Results of the ICTuS 2 trial (Intravascular Cooling in the Treatment of Stroke 2).","volume":"47","author":"Lyden","year":"2016","journal-title":"Stroke"},{"issue":"9","key":"noi210017r75","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1161\/STROKEAHA.116.013372","article-title":"Aspiration thrombectomy after intravenous alteplase versus intravenous alteplase alone.","volume":"47","author":"Mocco","year":"2016","journal-title":"Stroke"},{"issue":"11","key":"noi210017r76","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1056\/NEJMoa1603460","article-title":"Intensive blood-pressure lowering in patients with acute cerebral hemorrhage.","volume":"375","author":"Qureshi","year":"2016","journal-title":"N Engl J Med"},{"issue":"19","key":"noi210017r77","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1001\/jama.2016.16623","article-title":"Effect of conscious sedation vs general anesthesia on early neurological improvement among patients with ischemic stroke undergoing endovascular thrombectomy: a randomized clinical trial.","volume":"316","author":"Sch\u00f6nenberger","year":"2016","journal-title":"JAMA"},{"issue":"11","key":"noi210017r78","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/S1474-4422(16)30196-X","article-title":"Safety and efficacy of intravenous glyburide on brain swelling after large hemispheric infarction (GAMES-RP): a randomised, double-blind, placebo-controlled phase 2 trial.","volume":"15","author":"Sheth","year":"2016","journal-title":"Lancet Neurol"},{"issue":"12","key":"noi210017r79","doi-asserted-by":"publisher","first-page":"2880","DOI":"10.1161\/STROKEAHA.116.013715","article-title":"Desmoteplase 3 to 9 hours after major artery occlusion stroke: the DIAS-4 trial (efficacy and safety study of desmoteplase to treat acute ischemic stroke).","volume":"47","author":"von Kummer","year":"2016","journal-title":"Stroke"},{"issue":"6","key":"noi210017r80","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S1474-4422(15)00047-2","article-title":"Safety and efficacy of desmoteplase given 3-9 h after ischaemic stroke in patients with occlusion or high-grade stenosis in major cerebral arteries (DIAS-3): a double-blind, randomised, placebo-controlled phase 3 trial.","volume":"14","author":"Albers","year":"2015","journal-title":"Lancet Neurol"},{"issue":"9968","key":"noi210017r81","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/S0140-6736(14)61121-1","article-title":"Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial-factorial randomised controlled trial.","volume":"385","author":"Bath","year":"2015","journal-title":"Lancet"},{"issue":"1","key":"noi210017r82","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1411587","article-title":"A randomized trial of intraarterial treatment for acute ischemic stroke.","volume":"372","author":"Berkhemer","year":"2015","journal-title":"N Engl J Med"},{"issue":"9988","key":"noi210017r83","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/S0140-6736(15)60690-0","article-title":"Efficacy and safety of very early mobilisation within 24 h of stroke onset (AVERT): a randomised controlled trial.","volume":"386","author":"Bernhardt","year":"2015","journal-title":"Lancet"},{"issue":"11","key":"noi210017r84","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1056\/NEJMoa1414792","article-title":"Endovascular therapy for ischemic stroke with perfusion-imaging selection.","volume":"372","author":"Campbell","year":"2015","journal-title":"N Engl J Med"},{"issue":"11","key":"noi210017r85","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1056\/NEJMoa1414905","article-title":"Randomized assessment of rapid endovascular treatment of ischemic stroke.","volume":"372","author":"Goyal","year":"2015","journal-title":"N Engl J Med"},{"issue":"4","key":"noi210017r86","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/S1474-4422(15)70017-7","article-title":"Alteplase versus tenecteplase for thrombolysis after ischaemic stroke (ATTEST): a phase 2, randomised, open-label, blinded endpoint study.","volume":"14","author":"Huang","year":"2015","journal-title":"Lancet Neurol"},{"issue":"24","key":"noi210017r87","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1056\/NEJMoa1503780","article-title":"Thrombectomy within 8 hours after symptom onset in ischemic stroke.","volume":"372","author":"Jovin","year":"2015","journal-title":"N Engl J Med"},{"issue":"10006","key":"noi210017r88","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1016\/S0140-6736(15)00126-9","article-title":"Prophylactic antibiotics after acute stroke for reducing pneumonia in patients with dysphagia (STROKE-INF): a prospective, cluster-randomised, open-label, masked endpoint, controlled clinical trial.","volume":"386","author":"Kalra","year":"2015","journal-title":"Lancet"},{"issue":"22","key":"noi210017r89","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1212\/WNL.0000000000001639","article-title":"Cyclosporine in acute ischemic stroke.","volume":"84","author":"Nighoghossian","year":"2015","journal-title":"Neurology"},{"issue":"24","key":"noi210017r90","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1056\/NEJMoa1415061","article-title":"Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke.","volume":"372","author":"Saver","year":"2015","journal-title":"N Engl J Med"},{"issue":"6","key":"noi210017r91","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1056\/NEJMoa1408827","article-title":"Prehospital use of magnesium sulfate as neuroprotection in acute stroke.","volume":"372","author":"Saver","year":"2015","journal-title":"N Engl J Med"},{"issue":"9977","key":"noi210017r92","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1016\/S0140-6736(14)62456-9","article-title":"The Preventive Antibiotics in Stroke Study (PASS): a pragmatic randomised open-label masked endpoint clinical trial.","volume":"385","author":"Westendorp","year":"2015","journal-title":"Lancet"},{"issue":"2","key":"noi210017r93","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1161\/STROKEAHA.114.007006","article-title":"High-dose simvastatin for aneurysmal subarachnoid hemorrhage: multicenter randomized controlled double-blinded clinical trial.","volume":"46","author":"Wong","year":"2015","journal-title":"Stroke"},{"issue":"5","key":"noi210017r94","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/S1474-4422(14)70054-7","article-title":"Safety and efficacy of uric acid in patients with acute stroke (URICO-ICTUS): a randomised, double-blind phase 2b\/3 trial.","volume":"13","author":"Chamorro","year":"2014","journal-title":"Lancet Neurol"},{"issue":"11","key":"noi210017r95","doi-asserted-by":"publisher","first-page":"3187","DOI":"10.1161\/STROKEAHA.114.005795","article-title":"Transcranial laser therapy in acute stroke treatment: results of neurothera effectiveness and safety trial 3, a phase III clinical end point device trial.","volume":"45","author":"Hacke","year":"2014","journal-title":"Stroke"},{"issue":"5","key":"noi210017r96","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1001\/jama.2013.282543","article-title":"Effects of immediate blood pressure reduction on death and major disability in patients with acute ischemic stroke: the CATIS randomized clinical trial.","volume":"311","author":"He","year":"2014","journal-title":"JAMA"},{"issue":"1","key":"noi210017r97","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1161\/STROKEAHA.113.001346","article-title":"Remote ischemic perconditioning as an adjunct therapy to thrombolysis in patients with acute ischemic stroke: a randomized trial.","volume":"45","author":"Hougaard","year":"2014","journal-title":"Stroke"},{"issue":"12","key":"noi210017r98","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1056\/NEJMoa1311367","article-title":"Hemicraniectomy in older patients with extensive middle-cerebral-artery stroke.","volume":"370","author":"J\u00fcttler","year":"2014","journal-title":"N Engl J Med"},{"issue":"7","key":"noi210017r99","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/S1474-4422(14)70084-5","article-title":"Simvastatin in aneurysmal subarachnoid haemorrhage (STASH): a multicentre randomised phase 3 trial.","volume":"13","author":"Kirkpatrick","year":"2014","journal-title":"Lancet Neurol"},{"issue":"12","key":"noi210017r100","doi-asserted-by":"publisher","first-page":"3502","DOI":"10.1161\/STROKEAHA.114.005661","article-title":"Randomized controlled trial of early rehabilitation after intracerebral hemorrhage stroke: difference in outcomes within 6 months of stroke.","volume":"45","author":"Liu","year":"2014","journal-title":"Stroke"},{"issue":"5","key":"noi210017r101","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1161\/STROKEAHA.114.004739","article-title":"Early intensive versus minimally invasive approach to postoperative hemodynamic management after subarachnoid hemorrhage.","volume":"45","author":"Mutoh","year":"2014","journal-title":"Stroke"},{"issue":"25","key":"noi210017r102","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1056\/NEJMoa1214609","article-title":"Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage.","volume":"368","author":"Anderson","year":"2013","journal-title":"N Engl J Med"},{"issue":"10","key":"noi210017r103","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1056\/NEJMoa1214300","article-title":"Endovascular therapy after intravenous t-PA versus t-PA alone for stroke.","volume":"368","author":"Broderick","year":"2013","journal-title":"N Engl J Med"},{"issue":"8","key":"noi210017r104","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1161\/STROKEAHA.113.002055","article-title":"Chinese medicine neuroaid efficacy on stroke recovery: a double-blind, placebo-controlled, randomized study.","volume":"44","author":"Chen","year":"2013","journal-title":"Stroke"},{"issue":"10","key":"noi210017r105","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1056\/NEJMoa1213701","article-title":"Endovascular treatment for acute ischemic stroke.","volume":"368","author":"Ciccone","year":"2013","journal-title":"N Engl J Med"},{"issue":"9891","key":"noi210017r106","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/S0140-6736(13)61050-8","article-title":"Effectiveness of intermittent pneumatic compression in reduction of risk of deep vein thrombosis in patients who have had a stroke (CLOTS 3): a multicentre randomised controlled trial.","volume":"382","author":"Dennis","year":"2013","journal-title":"Lancet"},{"issue":"11","key":"noi210017r107","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/S1474-4422(13)70223-0","article-title":"High-dose albumin treatment for acute ischaemic stroke (ALIAS) part 2: a randomised, double-blind, phase 3, placebo-controlled trial.","volume":"12","author":"Ginsberg","year":"2013","journal-title":"Lancet Neurol"},{"issue":"10","key":"noi210017r108","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1056\/NEJMoa1212793","article-title":"A trial of imaging selection and endovascular treatment for ischemic stroke.","volume":"368","author":"Kidwell","year":"2013","journal-title":"N Engl J Med"},{"issue":"3","key":"noi210017r109","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1161\/STROKEAHA.111.000013","article-title":"Results of membrane-activated chelator stroke intervention randomized trial of DP-b99 in acute ischemic stroke.","volume":"44","author":"Lees","year":"2013","journal-title":"Stroke"},{"issue":"9890","key":"noi210017r110","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S0140-6736(13)60986-1","article-title":"Early surgery versus initial conservative treatment in patients with spontaneous supratentorial lobar intracerebral haematomas (STICH II): a randomised trial.","volume":"382","author":"Mendelow","year":"2013","journal-title":"Lancet"},{"issue":"9","key":"noi210017r111","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1161\/STROKEAHA.113.001059","article-title":"Combined approach to lysis utilizing eptifibatide and recombinant tissue plasminogen activator in acute ischemic stroke-enhanced regimen stroke trial.","volume":"44","author":"Pancioli","year":"2013","journal-title":"Stroke"},{"issue":"6","key":"noi210017r112","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1212\/WNL.0b013e318281550e","article-title":"Shoulder taping reduces injury and pain in stroke patients: randomized controlled trial.","volume":"80","author":"Pandian","year":"2013","journal-title":"Neurology"},{"issue":"10","key":"noi210017r113","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.1161\/STROKEAHA.113.001531","article-title":"Granulocyte colony-stimulating factor in patients with acute ischemic stroke: results of the AX200 for Ischemic Stroke trial.","volume":"44","author":"Ringelstein","year":"2013","journal-title":"Stroke"},{"issue":"3","key":"noi210017r114","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1161\/STROKEAHA.111.625731","article-title":"Lumbar drainage of cerebrospinal fluid after aneurysmal subarachnoid hemorrhage: a prospective, randomized, controlled trial (LUMAS).","volume":"43","author":"Al-Tamimi","year":"2012","journal-title":"Stroke"},{"issue":"9839","key":"noi210017r115","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/S0140-6736(12)60813-7","article-title":"Citicoline in the treatment of acute ischaemic stroke: an international, randomised, multicentre, placebo-controlled study (ICTUS trial).","volume":"380","author":"D\u00e1valos","year":"2012","journal-title":"Lancet"},{"issue":"6","key":"noi210017r116","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1161\/STROKEAHA.111.648980","article-title":"Randomized trial of clazosentan in patients with aneurysmal subarachnoid hemorrhage undergoing endovascular coiling.","volume":"43","author":"Macdonald","year":"2012","journal-title":"Stroke"},{"issue":"9836","key":"noi210017r117","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/S0140-6736(12)60724-7","article-title":"Magnesium for aneurysmal subarachnoid haemorrhage (MASH-2): a randomised placebo-controlled trial.","volume":"380","author":"Dorhout Mees","year":"2012","journal-title":"Lancet"},{"issue":"9849","key":"noi210017r118","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/S0140-6736(12)61299-9","article-title":"Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial.","volume":"380","author":"Nogueira","year":"2012","journal-title":"Lancet"},{"issue":"9","key":"noi210017r119","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1161\/STROKEAHA.112.657122","article-title":"Intensive versus subcutaneous insulin in patients with hyperacute stroke: results from the randomized INSULINFARCT trial.","volume":"43","author":"Rosso","year":"2012","journal-title":"Stroke"},{"issue":"9834","key":"noi210017r120","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1016\/S0140-6736(12)60768-5","article-title":"The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial.","volume":"379","author":"Sandercock","year":"2012","journal-title":"Lancet"},{"issue":"9849","key":"noi210017r121","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/S0140-6736(12)61384-1","article-title":"Solitaire flow restoration device versus the Merci retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial.","volume":"380","author":"Saver","year":"2012","journal-title":"Lancet"},{"issue":"9","key":"noi210017r122","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1161\/STROKEAHA.111.646687","article-title":"Outcome after mobilization within 24 hours of acute stroke: a randomized controlled trial.","volume":"43","author":"Sundseth","year":"2012","journal-title":"Stroke"},{"issue":"9843","key":"noi210017r123","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/S0140-6736(12)60949-0","article-title":"Early administration of aspirin in patients treated with alteplase for acute ischaemic stroke: a randomised controlled trial.","volume":"380","author":"Zinkstok","year":"2012","journal-title":"Lancet"},{"issue":"2","key":"noi210017r124","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S1474-4422(10)70314-8","article-title":"Fluoxetine for Motor Recovery After Acute Ischaemic Stroke (FLAME): a randomised placebo-controlled trial.","volume":"10","author":"Chollet","year":"2011","journal-title":"Lancet Neurol"},{"issue":"10","key":"noi210017r125","doi-asserted-by":"publisher","first-page":"2883","DOI":"10.1161\/STROKEAHA.110.609370","article-title":"Efficacy and safety of combination antiplatelet therapies in patients with symptomatic intracranial atherosclerotic stenosis.","volume":"42","author":"Kwon","year":"2011","journal-title":"Stroke"},{"issue":"7","key":"noi210017r126","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/S1474-4422(11)70108-9","article-title":"Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2).","volume":"10","author":"Macdonald","year":"2011","journal-title":"Lancet Neurol"},{"issue":"9767","key":"noi210017r127","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/S0140-6736(11)60104-9","article-title":"The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial.","volume":"377","author":"Sandset","year":"2011","journal-title":"Lancet"},{"issue":"6","key":"noi210017r128","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1161\/STROKEAHA.110.609933","article-title":"Partial aortic occlusion for cerebral perfusion augmentation: safety and efficacy of NeuroFlo in Acute Ischemic Stroke trial.","volume":"42","author":"Shuaib","year":"2011","journal-title":"Stroke"},{"issue":"9","key":"noi210017r129","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1161\/STROKEAHA.110.599662","article-title":"Safety of tirofiban in acute ischemic stroke: the SaTIS trial.","volume":"42","author":"Siebler","year":"2011","journal-title":"Stroke"},{"issue":"2","key":"noi210017r130","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S1474-4422(09)70361-8","article-title":"Early treatment with aspirin plus extended-release dipyridamole for transient ischaemic attack or ischaemic stroke within 24 h of symptom onset (EARLY trial): a randomised, open-label, blinded-endpoint trial.","volume":"9","author":"Dengler","year":"2010","journal-title":"Lancet Neurol"},{"issue":"8","key":"noi210017r131","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/S1474-4422(10)70163-0","article-title":"Effects of antihypertensive treatment after acute stroke in the Continue or Stop Post-Stroke Antihypertensives Collaborative Study (COSSACS): a prospective, randomised, open, blinded-endpoint trial.","volume":"9","author":"Robinson","year":"2010","journal-title":"Lancet Neurol"},{"issue":"5","key":"noi210017r132","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S1474-4422(10)70060-0","article-title":"Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): a randomised, open-label, blinded-endpoint trial.","volume":"9","author":"Wong","year":"2010","journal-title":"Lancet Neurol"},{"issue":"5","key":"noi210017r133","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1161\/STROKEAHA.109.571125","article-title":"Intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage (IMASH): a randomized, double-blinded, placebo-controlled, multicenter phase III trial.","volume":"41","author":"Wong","year":"2010","journal-title":"Stroke"},{"issue":"4","key":"noi210017r134","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1161\/STROKEAHA.108.540781","article-title":"Sex differences in stroke epidemiology: a systematic review.","volume":"40","author":"Appelros","year":"2009","journal-title":"Stroke"},{"issue":"3","key":"noi210017r135","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1159\/000319457","article-title":"Gender imbalances induced by age limits in stroke trials.","volume":"35","author":"Foerch","year":"2010","journal-title":"Neuroepidemiology"},{"issue":"2","key":"noi210017r136","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1161\/STROKEAHA.120.033227","article-title":"Under-enrollment of women in stroke clinical trials: what are the causes and what should be done about it?","volume":"52","author":"Carcel","year":"2021","journal-title":"Stroke"},{"issue":"1","key":"noi210017r137","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.010235","article-title":"Sex differences in severity of stroke in the INSTRUCT study: a meta-analysis of individual participant data.","volume":"8","author":"Phan","year":"2019","journal-title":"J Am Heart Assoc"},{"issue":"15","key":"noi210017r138","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1212\/WNL.0000000000003198","article-title":"Why are acute ischemic stroke patients not receiving IV tPA? results from a national registry.","volume":"87","author":"Mess\u00e9","year":"2016","journal-title":"Neurology"},{"issue":"12","key":"noi210017r139","doi-asserted-by":"publisher","first-page":"3494","DOI":"10.1161\/STROKEAHA.119.026723","article-title":"Age and sex differences in ischemic stroke treatment in a nationwide analysis of 1.11 million hospitalized cases.","volume":"50","author":"Weber","year":"2019","journal-title":"Stroke"},{"issue":"19","key":"noi210017r140","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1212\/WNL.0b013e3181a55fbe","article-title":"Who will participate in acute stroke trials?","volume":"72","author":"Kasner","year":"2009","journal-title":"Neurology"},{"issue":"1","key":"noi210017r141","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1186\/s13063-019-3434-0","article-title":"Who says \u201cno\u201d to participating in stroke clinical trials and why: an observational study from the Vancouver Stroke Program.","volume":"20","author":"O\u2019Neill","year":"2019","journal-title":"Trials"},{"issue":"8","key":"noi210017r142","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-008378","article-title":"Exploring threats to generalisability in a large international rehabilitation trial (AVERT).","volume":"5","author":"Bernhardt","year":"2015","journal-title":"BMJ Open"},{"issue":"9","key":"noi210017r143","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1001\/archinte.167.9.905","article-title":"Sex differences in perceived risks, distrust, and willingness to participate in clinical trials: a randomized study of cardiovascular prevention trials.","volume":"167","author":"Ding","year":"2007","journal-title":"Arch Intern Med"},{"issue":"1","key":"noi210017r144","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1097\/01.mlr.0000188911.83349.a8","article-title":"Gender differences in stroke care decision-making.","volume":"44","author":"Kapral","year":"2006","journal-title":"Med Care"},{"issue":"1","key":"noi210017r145","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/ane.2007.115.issue-1","article-title":"Lund Stroke Register: hospitalization pattern and yield of different screening methods for first-ever stroke.","volume":"115","author":"Hallstr\u00f6m","year":"2007","journal-title":"Acta Neurol Scand"},{"issue":"9499","key":"noi210017r146","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1016\/S0140-6736(05)67702-1","article-title":"Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study).","volume":"366","author":"Rothwell","year":"2005","journal-title":"Lancet"},{"issue":"4","key":"noi210017r147","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1177\/1740774514538706","article-title":"Screen failure data in clinical trials: are screening logs worth it?","volume":"11","author":"Elm","year":"2014","journal-title":"Clin Trials"}],"container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/articlepdf\/2778649\/jamaneurology_strong_2021_oi_210017_1622672561.44206.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T15:30:24Z","timestamp":1623339024000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/2778649"}},"subtitle":["A Meta-analysis"],"short-title":[],"issued":{"date-parts":[[2021,6,1]]},"references-count":147,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2021.0873","relation":{},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6,1]]}}}